The global medical ceramics market is anticipated to grow significantly over the forecast period. Ceramics are products manufactured by firing non-metallic materials at high temperatures. Some of the materials used in producing ceramics include alumina, zirconia (TZP), single-crystal piezoelectric, silicon nitride (Si3N4), macor, dielectrics, braze alloys, zirconia toughened alumina and silicon carbide (SiC). Some of the major medical applications of these ceramics include implantable medical devices, diagnostic imaging equipment, consumable medical devices, and other therapeutic medical devices.
A growing number of medical procedures involving dental implants, cardiovascular implants, orthopedic implants, and medical imaging equipment is one of the major drivers of this market. This growing number of medical procedures is a consequence of factors such as the rising demand for minimally invasive medical procedures, the introduction of innovative products increasing the efficacy of therapeutic and diagnostic medical procedures and constantly improving healthcare infrastructure across the globe. Some of the other drivers of the global medical ceramics market include the rising incidence rates of cardiovascular, orthopedic, and dental diseases and the growing global base of the elderly population.
North America currently holds the majority of the market share and is expected to maintain its position throughout the forecast period. High usage rates of implantable medical devices and diagnostic imaging equipment coupled with the presence of a relatively larger number of medical device manufacturers in this region are some of the factors accounting for its large market share. However, the Asia-Pacific medical ceramics market is expected to grow at the fastest rate during the forecast period owing to drivers such as the rising demand for medical device outsourcing in emerging economies such as India and China, the presence of high unmet medical needs and constantly improving healthcare infrastructure in this region. Furthermore, the fact that Asian countries such as China produce cost-effective medical devices catering to patients with lower disposable incomes, will serve the Asia-Pacific medical ceramics market as a driver.
This research study encompasses a competitive landscape of the medical ceramics market. Revenue analysis, product benchmarking, and strategic developments of key market players such as 3M ESPE AG, Rockwood Holdings, Morgan Advanced Materials PLC, Noritake, Tosoh Corporation, and others are also provided in this report.
This report, by Grand View Research, takes a closer look at the medical ceramics industry, providing a holistic perspective on market dynamics, trends, supply, and demand. The report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro-level. The study aims at providing granular information, regarding estimates and forecasts for key application segments including dental, implantable electronic medical devices, orthopedic, surgical and diagnostic equipment and others. The report also provides the same level of information for key regional markets.
This research report analyzes various factors which have been driving and inhibiting the global medical ceramics market in the past. Also, the report analyzes the impact of each driver and restraint on the market growth, which forms the base for the market forecast. The report also showcases the opportunities available in the market which may act as future drivers for the market.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.